testosterone/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on incidence of cardiovascular disease (composite)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no difference between the testosterone replacement therapy group (120/1601, 7.5%) and placebo group (110/1519, 7.2%) in the incidence of cardiovascular and/or cerebrovascular events (13 studies, odds ratio 1.07, 95% confidence interval 0.81 to 1.42; p = 0.62).”
Quoted verbatim from The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.. - Study
- meta-analysis
- Population
- Men with male hypogonadism; individual participant data and aggregate meta-analysis of placebo-controlled randomised trials of any testosterone replacement formulation (13 studies for this endpoint)
Effect 1.07 odds ratio, 95% CI 0.81 to 1.42
The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.2024PMID:39248210Permalink
Keep reading
- Everything the graph holds on testosterone
- Every compound studied against Incidence of cardiovascular disease (composite)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45CBTMJEAPYF70A848SDZHQ